Hennessy Balanced Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Hennessy Balanced Fund Investor Class HBFBX
- NAV / 1-Day Return 13.40 / −0.07 %
- Total Assets 13.7M
-
Adj. Expense Ratio
1.880%
- Expense Ratio 1.880%
- Distribution Fee Level High
- Share Class Type No Load
- Category Moderately Conservative Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity —
- Status Open
- TTM Yield 1.64%
- Turnover 39%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:53 AM GMT+0
Morningstar’s Analysis HBFBX
Will HBFBX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 44.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
United States Treasury Bills 0% | 14.30 | 2M | Government |
United States Treasury Bills 0% | 13.71 | 2M | Government |
United States Treasury Bills 0% | 12.60 | 2M | Government |
United States Treasury Bills 0% | 7.82 | 1M | Government |
Merck & Co Inc | 6.02 | 828,825 | Healthcare |
Coca-Cola Co | 5.11 | 702,986 | Consumer Defensive |
Amgen Inc | 5.00 | 688,028 | Healthcare |
UnitedHealth Group Inc | 4.98 | 685,790 | Healthcare |
Procter & Gamble Co | 4.58 | 630,552 | Consumer Defensive |
Chevron Corp | 4.57 | 629,888 | Energy |